Therapy of Severe Acute Respiratory Syndrome Coronavirus 2 Pneumonia: Is There an Optimal Interleukin 6 Cutoff for Successful Tocilizumab Treatment?
Nicola SquillaceMaria Rosa PozziGiulia GustinettiElena RicciSerena CapiciPaola ColumpsiLuca SalaPaolo BonfantiPublished in: Clinical infectious diseases : an official publication of the Infectious Diseases Society of America (2021)
Keyphrases